Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative Glucose Monitoring for SSI Reduction
NCT06765655Enrolling by invitation
- Sponsor
- Saint Peter's Healthcare System
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of insulin lispro in Stress Hyperglycemia (SH) and diabetes mellitus (DM), sponsored by Saint Peter's Healthcare System. Primary endpoint: Surgical Site Infections at 30 days. Started Apr 2024; status: enrolling by invitation.
02
Drugs
insulin lispro
03
Conditions
Stress Hyperglycemia (SH)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT06765655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06765655.